A useful VAPT engagement should leave the company with more than a vulnerability list. The minimum business outcome is a defensible understanding of what was tested, which attack paths were validated, what the findings mean to the product, what must be fixed first, what remains uncertain and how closure will be verified. If the deliverables cannot support engineering action, executive risk decisions and external assurance, the engagement is incomplete even when the testing itself was technically competent.
Founders should agree these outputs before signing the statement of work. Otherwise, a vendor can deliver a large document that satisfies the contract while leaving the team to reconstruct scope, reproduce findings, decide priority and negotiate retesting. The best deliverables create a shared operating picture for leadership, engineering and security without pretending one document serves every audience equally.
Start with a coverage record
The report should identify the assessed application, build or version, domains, APIs, mobile builds, environments, roles, tenants and testing dates. It should also state exclusions, unavailable accounts, blocked paths, unstable components and any production constraints that limited confidence. This is the foundation for interpreting every finding and for deciding when the evidence becomes stale.
- Target inventory and assessed release identifier.
- User roles, privilege levels and tenant combinations exercised.
- Critical workflows and integrations included in manual testing.
- Testing window, source addresses and relevant rules of engagement.
- Explicit exclusions, incomplete coverage and assumptions.
Avoid scope descriptions that say only “web application” or list one URL. A buyer must be able to tell whether the report covered authenticated workflows, backend APIs and authorization boundaries—not merely the public interface.
Require findings that engineers can reproduce
Each finding should name the affected asset and condition, explain the violated control, provide safe reproduction steps and evidence, describe realistic impact, justify severity and recommend remediation at the correct layer. Generic advice such as “validate input” or “use best practices” is not enough. The engineer should understand both the immediate fix and the root cause that could recur elsewhere.
Evidence
Screenshots can help, but request-and-response details, identities, preconditions and state changes are often more useful. Sensitive data should be minimized or redacted. Evidence must be sufficient for authorized reproduction without becoming an unsafe exploitation package.
Severity and business context
A numeric score does not replace reasoning. The report should explain exposure, privileges required, affected data or action, exploit reliability and product-specific consequence. Leadership can then distinguish a severe technical condition from a material business risk and can see where compensating controls reduce—but do not erase—risk.
Remediation guidance
Good guidance identifies the control boundary: server-side authorization, session invalidation, data validation, configuration, secrets management or workflow design. It may include examples, but it should not prescribe a framework-specific patch without understanding the codebase. The vendor should be available to clarify the finding with the engineering owner.
Ask for three views of the result
- An executive view: decision, exposure, material attack paths, limitations and residual risk.
- An engineering view: reproducible evidence, affected components, root cause, priority and remediation guidance.
- An assurance view: scope, method, dates, assessor identity, status and retest evidence suitable for authorized third-party sharing.
These views can live in one structured report or in separate artifacts. What matters is that technical detail is not removed to make the executive summary readable, and sensitive evidence is not distributed broadly merely because a customer needs proof that testing occurred.
The OWASP Web Security Testing Guide provides a broad testing framework. A vendor can reference relevant testing areas, but the final coverage statement must connect them to your product’s actual identities, workflows and APIs rather than presenting a checklist as proof of completeness.
Include an early critical-finding channel
Do not make the final report the first moment the company learns about a validated critical weakness. Agree who receives urgent notifications, how quickly, through which secure channel and with what minimum evidence. The alert should be clear enough to support containment or remediation while the full assessment continues.
Also define who may authorize a pause. A serious production impact, exposed real customer data or evidence of an active compromise may require the test to stop and incident response to begin. This operational deliverable belongs in the rules of engagement, not in an appendix nobody reads.
Turn the readout into a remediation plan
A report handover should not be a slide presentation followed by silence. Require a technical readout where testers explain attack paths, answer reproduction questions, group related findings by root cause and identify fixes that remove multiple symptoms. Engineering owners should leave with priority, next action and an agreed route for clarification.
- Assign an owner and target date to each accepted remediation item.
- Record disputed facts separately from accepted risk; do not resolve either by deleting evidence.
- Identify systemic fixes that should be searched for across similar components.
- Document temporary mitigations and the conditions under which they are sufficient.
- Reserve retest dates and prerequisites before the project team disperses.
Define retesting and closure precisely
Retesting should verify the reported issue, the affected control and reasonable bypass paths. Merely checking that one request now fails can miss alternate roles, endpoints or sequences. The agreement should state how many cycles or findings are included, how fixes are submitted, when retesting starts and whether closure appears in an updated report, addendum or signed letter.
Closure status should distinguish fixed, partially fixed, mitigated, risk accepted, not reproducible and not retested. “Closed” without the basis for closure creates weak evidence for customers and future teams. Preserve the original finding and add the retest result rather than rewriting history.
Useful optional deliverables
- A role-and-endpoint coverage matrix for complex authorization testing.
- A prioritized attack-path diagram showing how findings combine.
- A customer-safe executive letter with sensitive evidence removed.
- A standards mapping when an audit or contract explicitly requires it.
- A recurring-test baseline that highlights product changes for the next cycle.
- A secure evidence archive with retention and deletion dates.
Optional does not mean universally valuable. Buy these artifacts when they support a real consumer or recurring process. A massive standards appendix that nobody will use can increase cost without improving risk reduction.
Red flags in a deliverable promise
- The sample report is mostly generic vulnerability descriptions or raw scanner output.
- There is no tested-version record, role coverage or limitations section.
- Severity is copied from a tool without product-specific consequence.
- The vendor will not provide a draft factual-review period.
- Retesting is described as included but has no scope, schedule or closure artifact.
- The provider guarantees a clean report or offers to remove valid findings.
- Sensitive evidence is emailed or shared without access and retention controls.
NIST SP 800-115 covers planning, conducting technical tests, analyzing findings and developing mitigation strategies. The NIST testing guide reinforces why reporting and mitigation are part of the assessment lifecycle rather than administrative work added after testing.
Put acceptance criteria in the contract
List the required sections and formats, draft date, review window, final date, secure delivery method, readout participants, clarification period, retest entitlement and closure artifact. Require the report to state actual coverage and limitations. Acceptance should depend on completeness and evidence quality, not on receiving a predetermined number of findings.
Do not incentivize volume. Ten duplicated symptoms can be less valuable than one well-explained systemic authorization flaw. Equally, a report with no findings is not proof of quality; the coverage record and method must show what work supports that result.
The practical decision
Choose a VAPT partner whose outputs move cleanly from evidence to action: precise coverage, validated findings, audience-specific decisions, engineering clarification, remediation ownership, retesting and durable closure status. The final report matters, but the real deliverable is a reduction in uncertainty and a verified improvement in the product’s security posture.
Discuss WIMD’s penetration-testing deliverables using your report consumers and acceptance criteria. That conversation should happen before scope and price are finalized.
